by The global inhalation and nasal spray generic drugs market for the historical period 2017–2018 and forecast period 2019–2027, increasing prevalence of asthma and COPD disorders, and burgeoning demand for cost-effective generic drugs are projected to drive the global inhalation and nasal spray generic drugs market during the forecast period
According to the report, the global inhalation and nasal spray generic drugs market was valued at US$ 27.5 Bn in 2018 and is anticipated to expand at a CAGR of 4.80% from 2019 to 2027
Get the sample copy of report@ https://qyresearchmedical.com/sample/111888
Rising prevalence of asthma and COPD Disorders: Key Drivers
Asthma and chronic obstructive pulmonary disease (COPD) are considered serious health problems. These affect a large proportion of the global population. Smoking, tobacco use, and air pollution are few of the risk factors associated with asthma and COPD. According to the American Lung Association, smoking is the primary risk factor for COPD and approximately 80% of COPD-related deaths are caused by smoking.
According to Global Burden of Disease Study 2015, asthma and COPD were the most prevalent chronic respiratory disease, affecting over 360 and 175 million people in 2015, respectively.
Prevalence of asthma and COPD is increasing in developed countries due to modernized lifestyle. On the other hand, air pollution and high rate of smoking have led to higher prevalence of serious respiratory diseases in developing countries.
Increase in the geriatric population suffering from COPD and asthma is also expected to accelerate the growth of the inhalation and nasal spray generic drugs market
Stringent Regulations for Generic Drugs to Hamper Market
With the availability of growing number of low-cost generic inhalation and nasal spray drugs across the globe, various regulatory bodies have opted for stringent norms in order to focus on quality. Regulators in developing regions such as Brazil, Mexico, and Russia have changed their regulatory guidelines pertaining to the sale of generic drugs. This change in regulation norms has led to considerable delays in approval processes, thereby launch of generic drugs in these markets
Furthermore, the new regulatory laws in Russia mandate clinical trials for generic products as well, thereby creating hurdles for various pharmaceutical companies operating in the region. Similarly, the Drugs Controller General of India, a domestic drug regulatory body, constituted several new drug advisory committees to oversee and check clinical trials, new drug approval processes, etc.
Therefore, stringent and strict regulatory norms put up by various developing countries would lead to sluggish growth of the inhalation and nasal spray generic drugs market.
Global Inhalation and nasal spray generic drugs Market: Competitive Landscape
This report profiles major players in the global inhalation and nasal spray generic drugs market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The global inhalation and nasal spray generic drugs market is highly fragmented, with the presence of a number of international as well as regional players
Leading players operating in the global inhalation and nasal spray generic drugs market are
- Allergan plc
- Beximco Pharmaceuticals Ltd
- Cipla Limited
- Mylan N.V.
- Nephron Pharmaceuticals Corporation
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals PLC
- Sandoz International GmbH (a Novartis Division)
- Perrigo Company plc
- Catalent Pharma Solutions
- Teva Pharmaceutical Industries Ltd.
Key Questions Answered in Global Inhalation & Nasal Spray Generic Drugs Market Report
- What is the scope of growth of product companies in the global Inhalation & Nasal Spray Generic Drugs market?
- What will be the Y-o-Y growth of the global Inhalation & Nasal Spray Generic Drugs market between 2019 and 2027?
- What is the influence of changing trends in technologies on the global Inhalation & Nasal Spray Generic Drugs market?
- Will North America continue to be the most profitable market for Inhalation & Nasal Spray Generic Drugs providers?
- Which factors are anticipated to hamper the growth of the global Inhalation & Nasal Spray Generic Drugs market during the forecast period?
- Which are the leading companies in the global Inhalation & Nasal Spray Generic Drugs market?
Global Inhalation & Nasal Spray Generic Drugs Market – Segmentation
Drug Class
- Corticosteroids
- Fluticasone
- Budesonide
- Beclomethasone
- Flunisolide
- Others
- Bronchodilators
- Albuterol
- Epinephrine
- Others
- Antihistamines
- Combinations
- Salmeterol/Fluticasone
- Formoterol/Budesonide
- Azelastine/Benzalkonium Chloride
- Others
- Decongestant Sprays
- Phenylephrine Hydrochloride
- Oxymetazoline Hydrochloride
Indication
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Allergic Rhinitis
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111888/2900
